speb/financial-data huggingface dataset:
Financial ratios for CAPS — quarterly report dated 2025-09-30
Total revenue: 13990000
Gross profit: 3254000
Operating income: -116000
Net income: -2014000
Capital expenditures: 0
Operating cash flow: 0
Depreciation & amortization: 118000
Net tangible assets: 768000
Owner earnings: -1896000
Return on net tangible assets (%): -246.875
Buffett classification: The Gruesome
Stock price: 1.31
Shares outstanding: 15203173
Book value: 27157000
P/B ratio: 0.7333710141031778
Market cap (USD): 19916156.63
Debt to equity: 0.8563169716831756
Current ratio: 0.9546953046953047
Quick ratio: 0.3578921078921079
Interest coverage ratio: -0.19528619528619529
COGS to revenue (%): 74.33881343817012
SG&A to revenue (%): 24.08863473909936
Free cash flow (dilution-adjusted): -16000
Buyback yield (%): 0
Retained earnings: -201249000
Inventory turnover: 0.8704385671242049
Receivables turnover: 2.424189915092705
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.30158853963549387
FCF margin (%): -0.11436740528949249
Revenue growth (%): 6.04108239217767
Rule of 40 score: 5.926714986888178
Financial ratios for CAPS — annual report dated 2025-12-31
Total revenue: 48110000
Gross profit: 10791000
Operating income: -3583000
Net income: -21230000
Capital expenditures: 122000
Operating cash flow: -4412000
Depreciation & amortization: 391000
Net tangible assets: -7847000
Owner earnings: -20961000
Buffett classification: The Gruesome
Stock price: 0.73
Shares outstanding: 15203173
Book value: 12454000
P/B ratio: 0.8911447157539746
Market cap (USD): 11098316.29
Debt to equity: 2.3166854022803918
Current ratio: 1.003402547548421
Quick ratio: 0.2617780492060722
Interest coverage ratio: -0.9220277920741122
COGS to revenue (%): 75.01558927457909
SG&A to revenue (%): 29.87736437331116
Free cash flow (dilution-adjusted): -4572000
Buyback yield (%): 0
Retained earnings: -218037000
Inventory turnover: 2.12281630492324
Receivables turnover: 9.891036184210526
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.592254164616573
FCF margin (%): -9.50322178341301
Revenue growth (%): 5.025323087670277
Rule of 40 score: -4.477898695742734
Financial ratios for CAPS — quarterly report dated 2025-12-31
Total revenue: 12762000
Gross profit: 3082000
Operating income: -1779000
Net income: -16788000
Capital expenditures: 120000
Operating cash flow: -420000
Depreciation & amortization: 43000
Net tangible assets: -7847000
Owner earnings: -16865000
Buffett classification: The Gruesome
Stock price: 0.73
Shares outstanding: 15203173
Book value: 12454000
P/B ratio: 0.8911447157539746
Market cap (USD): 11098316.29
Debt to equity: 2.3166854022803918
Current ratio: 1.003402547548421
Quick ratio: 0.2617780492060722
Interest coverage ratio: -0.6971003134796239
COGS to revenue (%): 73.60915217050619
SG&A to revenue (%): 38.08964112208118
Free cash flow (dilution-adjusted): -562000
Buyback yield (%): 0
Retained earnings: -218037000
Inventory turnover: 0.5525557320157638
Receivables turnover: 2.6237664473684212
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.252196527728966
FCF margin (%): -4.403698479862091
Revenue growth (%): -8.77769835596855
Rule of 40 score: -13.18139683583064
Financial ratios for CEI.V — annual report dated 2022-12-31
Total revenue: 5759558.823529411
Gross profit: 2733823.5294117643
Operating income: -9683823.529411765
Net income: -8208088.235294117
Capital expenditures: 10223529.411764706
Operating cash flow: -7162499.999999999
Depreciation & amortization: 1386029.4117647058
Net tangible assets: 71380147.05882353
Owner earnings: -17045588.23529412
Return on net tangible assets (%): -23.880012773365475
Buffett classification: The Gruesome
Stock price: 0.5882352941176471
Shares outstanding: 633665079
Book value: 71380147.05882353
P/B ratio: 5.2219584783213335
Market cap (USD): 372744164.11764705
Debt to equity: 0.005562594641367162
Current ratio: 7.632625547691271
Quick ratio: 7.632625547691271
Interest coverage ratio: -88.38926174496645
COGS to revenue (%): 52.534150389378276
SG&A to revenue (%): 182.08859951487298
Free cash flow (dilution-adjusted): -24469117.647058822
Buyback yield (%): 0
Retained earnings: -4049264.705882353
Receivables turnover: 5.267652992602556
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.52758541967887
FCF margin (%): -424.8436103663986
Rule of 40 score: -424.8436103663986
Financial ratios for CEI.V — annual report dated 2023-12-31
Total revenue: 5047727.2727272725
Gross profit: 2159848.484848485
Operating income: -7023484.848484848
Net income: -4979545.454545454
Capital expenditures: 56525000
Operating cash flow: -3207575.7575757573
Depreciation & amortization: 1759848.4848484849
Net tangible assets: 130696212.12121211
Owner earnings: -59744696.96969697
Return on net tangible assets (%): -45.71264614332335
Buffett classification: The Gruesome
Stock price: 0.5681818181818181
Shares outstanding: 633665079
Book value: 130696212.12121212
P/B ratio: 2.754762137793518
Market cap (USD): 360036976.70454544
Debt to equity: 0.007129649487882493
Current ratio: 3.0470891006468666
Quick ratio: 3.0470891006468666
Interest coverage ratio: -42.527522935779814
COGS to revenue (%): 57.21146630646855
SG&A to revenue (%): 118.06993846615639
Free cash flow (dilution-adjusted): -62500757.57575758
Buyback yield (%): 0
Retained earnings: -9151515.15151515
Receivables turnover: 1.6098091326407344
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.14369729249889
FCF margin (%): -1238.1960078042925
Revenue growth (%): -12.359133270661415
Rule of 40 score: -1250.555141074954
Financial ratios for CEI.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.5703703703703703
Shares outstanding: 633665079
Market cap (USD): 361423785.79999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEI.V — annual report dated 2024-12-31
Total revenue: 9605594.405594407
Gross profit: 4372027.972027972
Operating income: -6735664.335664336
Net income: -6221678.321678322
Capital expenditures: 59088811.18881119
Operating cash flow: 1540559.4405594405
Depreciation & amortization: 3346853.146853147
Net tangible assets: 117502797.2027972
Owner earnings: -61963636.36363637
Return on net tangible assets (%): -52.73375429241381
Buffett classification: The Gruesome
Stock price: 0.5594405594405595
Shares outstanding: 633665079
Book value: 117502797.20279722
P/B ratio: 3.016931977218218
Market cap (USD): 354497946.2937063
Debt to equity: 0.009474554987531912
Current ratio: 0.31097921254767147
Quick ratio: 0.31097921254767147
Interest coverage ratio: -4.914285714285714
COGS to revenue (%): 54.48456610366919
SG&A to revenue (%): 65.27373325567851
Free cash flow (dilution-adjusted): -60287412.58741259
Buyback yield (%): 0
Retained earnings: -14960839.16083916
Receivables turnover: 2.904016913319239
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.478828695592819
FCF margin (%): -627.6281304601048
Revenue growth (%): 90.29543171821427
Rule of 40 score: -537.3326987418905
Financial ratios for CEI.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.5594405594405595
Shares outstanding: 633665079
Market cap (USD): 354497946.2937063
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEI.V — quarterly report dated 2025-03-31
Total revenue: 1864335.6643356644
Gross profit: 836363.6363636364
Operating income: -1983216.7832167833
Net income: -2529370.6293706293
Capital expenditures: 17972727.272727273
Operating cash flow: 816783.2167832168
Depreciation & amortization: 684615.3846153846
Net tangible assets: 115917482.51748252
Owner earnings: -19817482.51748252
Return on net tangible assets (%): -17.0961981636322
Buffett classification: The Gruesome
Stock price: 0.5734265734265734
Shares outstanding: 633665079
Book value: 115917482.51748252
P/B ratio: 3.1346470528830492
Market cap (USD): 363360394.951049
Debt to equity: 0.23274936354532402
Current ratio: 0.09528173512177511
Quick ratio: 0.09528173512177511
Interest coverage ratio: -3.2190692395005676
COGS to revenue (%): 55.13878469617405
SG&A to revenue (%): 103.26331582895725
Free cash flow (dilution-adjusted): -18039860.13986014
Buyback yield (%): 0
Retained earnings: -17490209.790209793
Receivables turnover: 1.323733862959285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4619460997587481
FCF margin (%): -967.6294073518379
Rule of 40 score: -967.6294073518379
Financial ratios for CEI.V — quarterly report dated 2025-06-30
Total revenue: 3524087.5912408754
Gross profit: 1834306.5693430656
Operating income: -1535036.4963503648
Net income: -2528467.1532846713
Capital expenditures: 10418248.17518248
Operating cash flow: -1332846.715328467
Depreciation & amortization: 1025547.4452554744
Net tangible assets: 119436496.35036495
Owner earnings: -11921167.883211678
Return on net tangible assets (%): -9.981176815703915
Buffett classification: The Gruesome
Stock price: 0.6131386861313868
Shares outstanding: 633665079
Book value: 119436496.35036495
P/B ratio: 3.252980335639377
Market cap (USD): 388524573.9854014
Debt to equity: 0.25387464248172686
Current ratio: 0.11940436895004267
Quick ratio: 0.11940436895004267
Interest coverage ratio: -1.4685754189944134
COGS to revenue (%): 47.94946147473074
SG&A to revenue (%): 54.72245236122618
Free cash flow (dilution-adjusted): -12579562.04379562
Buyback yield (%): 0
Retained earnings: -20784671.532846715
Receivables turnover: 1.165057915057915
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0975246982198494
FCF margin (%): -356.9594034797018
Revenue growth (%): 89.02645369371537
Rule of 40 score: -267.9329497859864
Financial ratios for CEI.V — quarterly report dated 2025-09-30
Total revenue: 8181294.964028778
Gross profit: 4281294.964028778
Operating income: -79136.69064748201
Net income: -1269064.748201439
Capital expenditures: 4391366.90647482
Operating cash flow: 3389928.057553957
Depreciation & amortization: 2228057.5539568346
Net tangible assets: 117374100.71942447
Owner earnings: -3432374.100719425
Return on net tangible assets (%): -2.9243027888446216
Buffett classification: The Gruesome
Stock price: 0.5899280575539568
Shares outstanding: 633665079
Book value: 117374100.71942449
P/B ratio: 3.184832146981305
Market cap (USD): 373816809.1942446
Debt to equity: 0.2747349065277352
Current ratio: 0.07561473590767864
Quick ratio: 0.07561473590767864
Interest coverage ratio: -0.06459189665296536
COGS to revenue (%): 47.66971508969399
SG&A to revenue (%): 22.370735138937743
Free cash flow (dilution-adjusted): -1829496.402877698
Buyback yield (%): 0
Retained earnings: -21754676.258992806
Receivables turnover: 3.3516062481579723
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.057702799110327746
FCF margin (%): -22.361941610974323
Revenue growth (%): 132.15356463793344
Rule of 40 score: 109.79162302695912
Financial ratios for CEI.V — quarterly report dated 2025-12-31
Total revenue: 8469343.06569343
Gross profit: 4808759.124087591
Operating income: -951094.8905109488
Net income: -1591970.802919708
Capital expenditures: 25208759.12408759
Operating cash flow: 3541605.8394160583
Depreciation & amortization: 2557664.2335766423
Net tangible assets: 118322627.73722626
Owner earnings: -24243065.693430655
Return on net tangible assets (%): -20.48895140096976
Buffett classification: The Gruesome
Stock price: 0.5912408759124087
Shares outstanding: 633665079
Book value: 118322627.73722628
P/B ratio: 3.1663317786948957
Market cap (USD): 374648696.3430657
Debt to equity: 0.4924368607420019
Current ratio: 0.12581474246941501
Quick ratio: 0.12581474246941501
Interest coverage ratio: -9.796992481203008
COGS to revenue (%): 43.22158062570025
SG&A to revenue (%): 26.80341291045419
Free cash flow (dilution-adjusted): -22312408.759124085
Buyback yield (%): 0
Retained earnings: -23664233.576642334
Receivables turnover: 2.0554472984942427
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5735918825523297
FCF margin (%): -263.4491079893131
Revenue growth (%): 3.52081306114903
Rule of 40 score: -259.92829492816406
Financial ratios for CEI.V — annual report dated 2025-12-31
Total revenue: 22240145.98540146
Gross profit: 11859854.01459854
Operating income: -4636496.3503649635
Net income: -8048175.182481751
Capital expenditures: 58842335.76642335
Operating cash flow: 6500729.927007299
Depreciation & amortization: 6558394.160583941
Net tangible assets: 118322627.73722626
Owner earnings: -60332116.78832116
Return on net tangible assets (%): -50.98950043799583
Buffett classification: The Gruesome
Stock price: 0.5912408759124087
Shares outstanding: 633665079
Book value: 118322627.73722628
P/B ratio: 3.1663317786948957
Market cap (USD): 374648696.3430657
Debt to equity: 0.4924368607420019
Current ratio: 0.12581474246941501
Quick ratio: 0.12581474246941501
Interest coverage ratio: -1.5309713183899736
COGS to revenue (%): 46.673668318618915
SG&A to revenue (%): 36.26308707210607
Free cash flow (dilution-adjusted): -55578102.18978102
Buyback yield (%): 0
Retained earnings: -23664233.576642334
Receivables turnover: 5.397519929140833
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.796205401360245
FCF margin (%): -249.89989825724507
Revenue growth (%): 131.53326120503846
Rule of 40 score: -118.36663705220661
Financial ratios for CEMX.TO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1392125.9842519686
Buffett classification: The Gruesome
Stock price: 0.25984251968503935
Shares outstanding: 149787365
Market cap (USD): 38921126.33858267
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEMX.TO — annual report dated 2022-12-31
Total revenue: 21325735.294117644
Gross profit: 1851470.588235294
Operating income: -3933088.2352941176
Net income: -4088970.588235294
Capital expenditures: 1320588.2352941176
Operating cash flow: -2355882.3529411764
Depreciation & amortization: 1364705.882352941
Net tangible assets: 15877941.176470587
Owner earnings: -4044852.9411764704
Return on net tangible assets (%): -25.474668889506347
Buffett classification: The Gruesome
Stock price: 0.16176470588235292
Shares outstanding: 149787365
Book value: 20398529.411764704
P/B ratio: 1.18784587628866
Market cap (USD): 24230309.044117644
Debt to equity: 0.2730516905774638
Current ratio: 1.9243482538121002
Quick ratio: 1.8249877029021149
Interest coverage ratio: -4.667539267015707
COGS to revenue (%): 91.31813950281006
SG&A to revenue (%): 27.124780195152226
Free cash flow (dilution-adjusted): -4188235.2941176468
Buyback yield (%): 0
Retained earnings: -17182352.94117647
Inventory turnover: 26.222772277227723
Receivables turnover: 3.952978056426332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.450737309147854
FCF margin (%): -19.639347653690997
Rule of 40 score: -19.639347653690997
Financial ratios for CEMX.TO — annual report dated 2023-12-31
Total revenue: 40375000
Gross profit: 8999242.424242424
Operating income: 1826515.1515151514
Net income: 935606.0606060605
Capital expenditures: 1385606.0606060605
Operating cash flow: 381060.606060606
Depreciation & amortization: 1701515.1515151514
Net tangible assets: 17212121.21212121
Owner earnings: 1251515.1515151514
Return on net tangible assets (%): 7.27112676056338
Capex to operating income (%): 75.8606387391124
Buffett classification: The Gruesome
Stock price: 0.21212121212121213
P/E ratio: 33.95988842105263
Shares outstanding: 149787365
Book value: 21759848.484848484
P/B ratio: 1.4601699752811337
Market cap (USD): 31773077.424242426
Debt to equity: 0.1129408487971312
Current ratio: 2.149368610944077
Quick ratio: 2.0244137101623574
Effective tax rate (%): 21.686746987951807
Interest coverage ratio: 3.9331158238172916
COGS to revenue (%): 77.71085467679895
SG&A to revenue (%): 17.765268786940613
Free cash flow (dilution-adjusted): -1355303.0303030303
Buyback yield (%): 0
Retained earnings: -16766666.666666666
Inventory turnover: 39.8614051973051
Receivables turnover: 4.14263505635445
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.786461697455109
FCF margin (%): -3.356787691153016
Revenue growth (%): 89.32524221632248
Rule of 40 score: 85.96845452516946
Financial ratios for CEMX.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.18518518518518517
Shares outstanding: 149787365
Market cap (USD): 27738400.925925925
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEMX.TO — annual report dated 2024-12-31
Total revenue: 24730069.93006993
Gross profit: 6585314.685314686
Operating income: -187412.58741258743
Net income: 188811.18881118883
Capital expenditures: 1351048.9510489511
Operating cash flow: 3423776.223776224
Depreciation & amortization: 1544755.2447552448
Net tangible assets: 21568531.46853147
Owner earnings: 382517.4825174825
Return on net tangible assets (%): 1.7734980384528092
Buffett classification: The Gruesome
Stock price: 0.18181818181818182
P/E ratio: 144.2396848148148
Shares outstanding: 149787365
Book value: 26135664.33566434
P/B ratio: 1.042026941189062
Market cap (USD): 27234066.363636363
Debt to equity: 0.0960025686305988
Current ratio: 5.145093653899916
Quick ratio: 4.912496505451496
Effective tax rate (%): -1250
Interest coverage ratio: -0.9816849816849818
COGS to revenue (%): 73.37122497455039
SG&A to revenue (%): 22.78871168419862
Free cash flow (dilution-adjusted): 1498601.3986013988
Buyback yield (%): 0
Retained earnings: -15288111.88811189
Inventory turnover: 31.186298076923077
Receivables turnover: 5.24532779590626
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6730624340750415
FCF margin (%): 6.059834860309921
Revenue growth (%): -38.74905280478036
Rule of 40 score: -32.68921794447044
Financial ratios for CEMX.TO — quarterly report dated 2024-12-31
Capital expenditures: 1296503.4965034965
Buffett classification: The Gruesome
Stock price: 0.18181818181818182
Shares outstanding: 149787365
Market cap (USD): 27234066.363636363
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEMX.TO — quarterly report dated 2025-03-31
Total revenue: 4636363.636363637
Gross profit: 1007692.3076923077
Operating income: -713286.7132867133
Net income: -633566.4335664336
Capital expenditures: 267832.1678321678
Operating cash flow: -1137762.237762238
Depreciation & amortization: 415384.6153846154
Net tangible assets: 21147552.44755245
Owner earnings: -486013.98601398605
Return on net tangible assets (%): -2.298204424456863
Buffett classification: The Gruesome
Stock price: 0.13286713286713286
Shares outstanding: 149787365
Book value: 25710489.510489512
P/B ratio: 0.7740738549203067
Market cap (USD): 19901817.727272727
Debt to equity: 0.10517869770984062
Current ratio: 8.178981184029372
Quick ratio: 7.852225791647545
Interest coverage ratio: -12.439024390243903
COGS to revenue (%): 78.26546003016591
SG&A to revenue (%): 37.11915535444947
Free cash flow (dilution-adjusted): -1624475.5244755247
Buyback yield (%): 0
Retained earnings: -15921678.321678322
Inventory turnover: 7.287921348314606
Receivables turnover: 0.822478600669892
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.528194323955881
FCF margin (%): -35.03770739064857
Rule of 40 score: -35.03770739064857
Financial ratios for CEMX.TO — quarterly report dated 2025-06-30
Total revenue: 7760583.941605839
Gross profit: 3016058.3941605836
Operating income: 1225547.4452554744
Net income: 972262.7737226277
Capital expenditures: 35036.49635036496
Operating cash flow: 550364.9635036496
Depreciation & amortization: 432116.78832116787
Net tangible assets: 22130656.93430657
Owner earnings: 1369343.0656934306
Return on net tangible assets (%): 6.187539166859065
Capex to operating income (%): 2.858844550327576
Buffett classification: The Great
Stock price: 0.2262773722627737
P/E ratio: 100.07043871432019
Shares outstanding: 149787365
Book value: 26650364.963503644
P/B ratio: 1.2717833844594781
Market cap (USD): 33893491.35036496
Debt to equity: 0.10027115115992442
Current ratio: 5.28321240930698
Quick ratio: 5.079309482111583
Effective tax rate (%): 12.541037426132634
Interest coverage ratio: 20.9875
COGS to revenue (%): 61.136192626034614
SG&A to revenue (%): 23.071858540255832
Free cash flow (dilution-adjusted): 445985.401459854
Buyback yield (%): 0.45225400342592964
Retained earnings: -15637226.277372262
Inventory turnover: 7.9754601226993875
Receivables turnover: 0.9454028098879602
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.168735723507797
FCF margin (%): 5.7468021068472535
Revenue growth (%): 67.3851438385573
Rule of 40 score: 73.13194594540455
Financial ratios for CEMX.TO — quarterly report dated 2025-09-30
Total revenue: 11015107.913669065
Gross profit: 3789208.6330935257
Operating income: 1990647.4820143885
Net income: 1373381.294964029
Capital expenditures: 68345.3237410072
Operating cash flow: 1263309.3525179857
Depreciation & amortization: 433812.9496402878
Net tangible assets: 23720143.884892087
Owner earnings: 1738848.9208633096
Return on net tangible assets (%): 7.330684540960239
Capex to operating income (%): 3.4333212865919776
Buffett classification: The Great
Stock price: 0.26618705035971224
P/E ratio: 23.28834630662283
Shares outstanding: 149787365
Book value: 28266187.050359715
P/B ratio: 1.4105707571901247
Market cap (USD): 39871456.8705036
Debt to equity: 0.09686943242555357
Current ratio: 3.8343390804597703
Quick ratio: 3.7038793103448278
Effective tax rate (%): 31.38030194104961
Interest coverage ratio: 33.74390243902439
COGS to revenue (%): 65.59989549996735
SG&A to revenue (%): 16.32813010254066
Free cash flow (dilution-adjusted): 1143884.892086331
Buyback yield (%): 0
Retained earnings: -14038129.496402878
Inventory turnover: 11.061674008810572
Receivables turnover: 0.9845669088804577
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.4138522519181285
FCF margin (%): 10.38469074521586
Revenue growth (%): 41.9365861712436
Rule of 40 score: 52.32127691645945
Financial ratios for CEMX.TO — annual report dated 2025-12-31
Total revenue: 32913138.686131384
Gross profit: 11541605.839416057
Operating income: 3796350.3649635036
Net income: 2963503.6496350365
Capital expenditures: 383211.67883211677
Operating cash flow: 2790510.9489051094
Depreciation & amortization: 1746715.3284671532
Net tangible assets: 25026277.372262772
Owner earnings: 4327007.299270073
Return on net tangible assets (%): 17.289855917867353
Capex to operating income (%): 10.094212651413189
Buffett classification: The Great
Stock price: 0.2627737226277372
P/E ratio: 13.281638275862068
Shares outstanding: 149787365
Book value: 29567153.28467153
P/B ratio: 1.331213158219567
Market cap (USD): 39360183.50364963
Debt to equity: 0.08460266126842274
Current ratio: 6.574317226890757
Quick ratio: 6.320903361344537
Effective tax rate (%): 15.69767441860465
Interest coverage ratio: 15.433234421364984
COGS to revenue (%): 64.93313521545319
SG&A to revenue (%): 19.791089130868688
Free cash flow (dilution-adjusted): 1994160.5839416056
Buyback yield (%): 0.7770274140872222
Retained earnings: -12997810.218978101
Inventory turnover: 30.340932642487047
Receivables turnover: 3.8615226513659326
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.851429873533098
FCF margin (%): 6.058858752300902
Revenue growth (%): 33.08954960176416
Rule of 40 score: 39.14840835406506
Financial ratios for CEMX.TO — quarterly report dated 2025-12-31
Total revenue: 9137956.20437956
Gross profit: 3629197.0802919706
Operating income: 1295620.4379562042
Net income: 1259124.0875912409
Capital expenditures: 0
Operating cash flow: 2146715.328467153
Depreciation & amortization: 440875.91240875906
Net tangible assets: 25026277.372262772
Owner earnings: 1700000
Return on net tangible assets (%): 6.792860059499504
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.2627737226277372
P/E ratio: 13.247226939452045
Shares outstanding: 149787365
Book value: 29567153.28467153
P/B ratio: 1.331213158219567
Market cap (USD): 39360183.50364963
Debt to equity: 0.08460266126842274
Current ratio: 6.574317226890757
Quick ratio: 6.320903361344537
Effective tax rate (%): -10.294117647058822
Interest coverage ratio: 17.401960784313726
COGS to revenue (%): 60.284367761003274
SG&A to revenue (%): 12.061666267273745
Free cash flow (dilution-adjusted): 2083211.6788321165
Buyback yield (%): 0.3875864666926717
Retained earnings: -12997810.218978101
Inventory turnover: 7.820725388601036
Receivables turnover: 1.0721075618737688
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.044662185256922
FCF margin (%): 22.797348030992893
Revenue growth (%): -17.041609796305995
Rule of 40 score: 5.755738234686898
Financial ratios for CHG.L — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.037361111111111116
Shares outstanding: 270551626
Market cap (USD): 10108109.36027778
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHG.L — annual report dated 2022-10-31
Total revenue: 466279069.76744187
Operating income: 57441860.46511628
Net income: 55116279.069767445
Capital expenditures: 29651162.790697675
Operating cash flow: 93604651.1627907
Depreciation & amortization: 25348837.209302325
Net tangible assets: 295348837.2093023
Owner earnings: 50813953.48837209
Return on net tangible assets (%): 17.20472440944882
Capex to operating income (%): 51.61943319838057
Buffett classification: The Good
Stock price: 0.032790697674418605
P/E ratio: 0.16096109394936708
Shares outstanding: 270551626
Book value: 486162790.6976745
P/B ratio: 0.018248160375986602
Market cap (USD): 8871576.573488371
Debt to equity: 0.06433867495814398
Current ratio: 1.5936675461741423
Quick ratio: 0.7176781002638521
Effective tax rate (%): 7.306889352818373
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 46046511.62790698
Buyback yield (%): 91.7484599980227
Retained earnings: 101395348.8372093
Inventory turnover: 0
Receivables turnover: 12.042042042042043
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.75513428120063
FCF margin (%): 9.875311720698255
Rule of 40 score: 9.875311720698255
Financial ratios for CHG.L — annual report dated 2023-10-31
Total revenue: 576341463.4146342
Operating income: 55365853.65853659
Net income: 6585365.853658537
Capital expenditures: 39878048.780487806
Operating cash flow: 80365853.65853658
Depreciation & amortization: 27195121.951219514
Net tangible assets: 305853658.5365854
Owner earnings: -6097560.975609757
Return on net tangible assets (%): -1.9936204146730463
Capex to operating income (%): 72.02643171806167
Buffett classification: The Good
Stock price: 0.0325609756097561
P/E ratio: 1.3377274841111109
Shares outstanding: 270551626
Book value: 461585365.85365856
P/B ratio: 0.019085147725759578
Market cap (USD): 8809424.895365855
Debt to equity: 0.05468956406869221
Current ratio: 1.2927515833919774
Quick ratio: 0.5770584095707249
Effective tax rate (%): 14.512471655328799
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 33292682.926829267
Buyback yield (%): 193.80573572616026
Retained earnings: 76707317.07317074
Inventory turnover: 0
Receivables turnover: 11.443099273607748
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.993396434074402
FCF margin (%): 5.776555226407109
Revenue growth (%): 23.60440362508365
Rule of 40 score: 29.380958851490757
Financial ratios for CHG.L — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 297662337.66233766
Buffett classification: The Gruesome
Stock price: 0.044805194805194806
Shares outstanding: 270551626
Book value: 462727272.7272727
P/B ratio: 0.026197112256525403
Market cap (USD): 12122118.307792207
Debt to equity: 0.2742071288240247
Current ratio: 1.5842630651790959
Quick ratio: 0.8379330593071053
Buyback yield (%): 0
Retained earnings: 67922077.92207792
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHG.L — annual report dated 2024-10-31
Total revenue: 634155844.1558441
Operating income: 73506493.50649351
Net income: 51298701.2987013
Capital expenditures: 81818181.81818181
Operating cash flow: 105194805.19480519
Depreciation & amortization: 31038961.038961038
Net tangible assets: 297662337.66233766
Owner earnings: 519480.51948052645
Return on net tangible assets (%): 0.17452006980803028
Capex to operating income (%): 111.30742049469964
Buffett classification: The Gruesome
Stock price: 0.044805194805194806
P/E ratio: 0.2363045847341772
Shares outstanding: 270551626
Book value: 462727272.7272727
P/B ratio: 0.026197112256525403
Market cap (USD): 12122118.307792207
Debt to equity: 0.2742071288240247
Current ratio: 1.5842630651790959
Quick ratio: 0.8379330593071053
Effective tax rate (%): 19.884169884169886
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): 9610389.610389609
Buyback yield (%): 439.2528755681732
Retained earnings: 67922077.92207792
Inventory turnover: 0
Receivables turnover: 10.592190889370931
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.847067842085092
FCF margin (%): 1.5154618062666392
Revenue growth (%): 10.031272155690242
Rule of 40 score: 11.546733961956882
Financial ratios for CHG.L — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 277866666.6666667
Buffett classification: The Gruesome
Stock price: 0.0524
Shares outstanding: 270551626
Book value: 470000000
P/B ratio: 0.03016362809021277
Market cap (USD): 14176905.2024
Debt to equity: 0.32851063829787236
Current ratio: 1.3695352047860103
Quick ratio: 0.6769443166129775
Buyback yield (%): 0
Retained earnings: 73466666.66666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHG.L — quarterly report dated 2025-10-31
Capital expenditures: 0
Net tangible assets: 287500000
Buffett classification: The Gruesome
Stock price: 0.07460526315789473
Shares outstanding: 270551626
Book value: 502631578.9473685
P/B ratio: 0.04015779370209423
Market cap (USD): 20184575.255526315
Debt to equity: 0.40392670157068056
Current ratio: 1.64746772591857
Quick ratio: 0.936444885799404
Buyback yield (%): 0
Retained earnings: 103289473.68421052
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHG.L — annual report dated 2025-10-31
Total revenue: 654605263.1578947
Operating income: 96578947.36842105
Net income: 63421052.631578945
Capital expenditures: 118684210.5263158
Operating cash flow: 119868421.05263157
Depreciation & amortization: 35263157.89473684
Net tangible assets: 287500000
Owner earnings: -20000000.000000015
Return on net tangible assets (%): -6.956521739130441
Capex to operating income (%): 122.88828337874659
Buffett classification: The Gruesome
Stock price: 0.07460526315789473
P/E ratio: 0.3182630123278008
Shares outstanding: 270551626
Book value: 502631578.9473685
P/B ratio: 0.04015779370209423
Market cap (USD): 20184575.255526315
Debt to equity: 0.40392670157068056
Current ratio: 1.64746772591857
Quick ratio: 0.936444885799404
Effective tax rate (%): 21.270310192023633
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -21447368.42105263
Buyback yield (%): 43.023994393630595
Retained earnings: 103289473.68421052
Inventory turnover: 0
Receivables turnover: 8.417935702199662
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.092640169260994
FCF margin (%): -3.276381909547739
Revenue growth (%): 3.224667751705712
Rule of 40 score: -0.05171415784202704
Financial ratios for CIZ.L — annual report dated 2021-12-31
Gross profit: 0
Capital expenditures: 270270.2702702703
Buffett classification: The Gruesome
Stock price: 0.0004054054054054054
Shares outstanding: 424963202
Market cap (USD): 172282.37918918917
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIZ.L — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 0
Operating income: -1160240.9638554216
Net income: -1098795.1807228916
Capital expenditures: 0
Operating cash flow: -1050602.4096385543
Net tangible assets: 674698.795180723
Owner earnings: -1098795.1807228916
Return on net tangible assets (%): -162.85714285714286
Buffett classification: The Gruesome
Stock price: 0.00012048192771084338
Shares outstanding: 424963202
Book value: 3180722.891566265
P/B ratio: 0.016097090984848485
Market cap (USD): 51200.38578313254
Debt to equity: 0
Current ratio: 4.862068965517241
Quick ratio: 4.862068965517241
Free cash flow (dilution-adjusted): -1228915.6626506024
Buyback yield (%): 0
Retained earnings: -7413253.012048193
Capitalized R&D asset: 337349.3975903615
ROCI (R&D-adjusted, %): -26.586757990867575
Rule of 40 score: 0
Financial ratios for CIZ.L — annual report dated 2023-12-31
Total revenue: 0
Operating income: -1235443.0379746836
Net income: -2173417.7215189873
Capital expenditures: 0
Operating cash flow: -808860.7594936709
Net tangible assets: 1907594.9367088606
Owner earnings: -2173417.7215189873
Return on net tangible assets (%): -113.93497013934973
Buffett classification: The Gruesome
Stock price: 0.00025316455696202533
Shares outstanding: 424963202
Book value: 1907594.9367088606
P/B ratio: 0.05639856695421367
Market cap (USD): 107585.62075949367
Debt to equity: 0
Current ratio: 9.102150537634408
Quick ratio: 9.102150537634408
Free cash flow (dilution-adjusted): -1197468.3544303798
Buyback yield (%): 0
Retained earnings: -9962025.316455696
Capitalized R&D asset: 496910.1723349093
ROCI (R&D-adjusted, %): -48.546460370637696
Rule of 40 score: 0
Financial ratios for CIZ.L — annual report dated 2024-12-31
Total revenue: 0
Operating income: -1097500
Net income: -2707500
Capital expenditures: 0
Operating cash flow: -447500
Net tangible assets: 102500
Owner earnings: -2707500
Return on net tangible assets (%): -2641.4634146341464
Buffett classification: The Gruesome
Stock price: 0.00025
Shares outstanding: 424963202
Book value: 102500
P/B ratio: 1.0364956146341464
Market cap (USD): 106240.8005
Debt to equity: 0
Current ratio: 1.2
Quick ratio: 1.1951219512195121
Free cash flow (dilution-adjusted): -650000
Buyback yield (%): 0
Retained earnings: -12545000
Inventory turnover: 0
Capitalized R&D asset: 559068.9720908953
ROCI (R&D-adjusted, %): -169.70946419964784
Rule of 40 score: 0
Financial ratios for CIZ.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 102500
Buffett classification: The Gruesome
Stock price: 0.00025
Shares outstanding: 424963202
Book value: 102500
P/B ratio: 1.0364956146341464
Market cap (USD): 106240.8005
Debt to equity: 0
Current ratio: 1.2
Quick ratio: 1.1951219512195121
Buyback yield (%): 0
Retained earnings: -12545000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIZ.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -378082.19178082194
Buffett classification: The Gruesome
Stock price: 0.00027397260273972606
Shares outstanding: 424963202
Book value: -378082.1917808219
Market cap (USD): 116428.27452054796
Debt to equity: -0.5434782608695653
Current ratio: 0.47842401500938087
Quick ratio: 0.476547842401501
Buyback yield (%): 0
Retained earnings: -14252054.794520548
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTAS — annual report dated 2021-05-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 84.37
Shares outstanding: 400147000
Market cap (USD): 33760402390
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTAS — annual report dated 2022-05-31
Total revenue: 7854459000
Gross profit: 3632246000
Operating income: 1587370000
Net income: 1235757000
Capital expenditures: 240672000
Operating cash flow: 1537625000
Depreciation & amortization: 399701000
Net tangible assets: -126418000
Owner earnings: 1394786000
Return on net tangible assets (%): -1103.3128193769874
Capex to operating income (%): 15.161682531482892
Buffett classification: The Great
Stock price: 95.99
P/E ratio: 31.0822520366059
Shares outstanding: 400147000
Book value: 3308196000
P/B ratio: 11.61059094745293
Market cap (USD): 38410110530
Debt to equity: 0.8972993135835966
Current ratio: 1.8368353467467844
Quick ratio: 0.8675662472346097
Effective tax rate (%): 17.54847981809059
Interest coverage ratio: 17.866935302327676
COGS to revenue (%): 53.75561830547464
SG&A to revenue (%): 26.03458748718403
Free cash flow (dilution-adjusted): 1187645000
Buyback yield (%): 3.972581643076048
Retained earnings: 8719163000
Inventory turnover: 3.0400653487474583
Receivables turnover: 7.641059490547976
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.64139816030285
FCF margin (%): 15.120646756192885
Rule of 40 score: 15.120646756192885
Financial ratios for CTAS — annual report dated 2023-05-31
Total revenue: 8815769000
Gross profit: 4173368000
Operating income: 1802664000
Net income: 1348010000
Capital expenditures: 0
Operating cash flow: 1586228000
Depreciation & amortization: 419344000
Net tangible assets: 461211000
Owner earnings: 1767354000
Return on net tangible assets (%): 383.19857939207867
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 114.95
P/E ratio: 34.12207450241467
Shares outstanding: 400147000
Book value: 3863986000
P/B ratio: 11.90400214959371
Market cap (USD): 45996897650
Debt to equity: 0.6905804006536256
Current ratio: 2.3888706422928276
Quick ratio: 1.1543621378434583
Effective tax rate (%): 20.384396402440895
Interest coverage ratio: 16.206343498273878
COGS to revenue (%): 52.660193342180364
SG&A to revenue (%): 26.891630213994944
Free cash flow (dilution-adjusted): 1151498000
Buyback yield (%): 0.8671563091820824
Retained earnings: 9597315000
Inventory turnover: 3.0571838932857083
Receivables turnover: 7.645986575807485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.63903172835865
FCF margin (%): 13.061798692774277
Revenue growth (%): 12.239035177343213
Rule of 40 score: 25.30083387011749
Financial ratios for CTAS — annual report dated 2024-05-31
Total revenue: 9596615000
Gross profit: 4686416000
Operating income: 2068633000
Net income: 1571592000
Capital expenditures: 0
Operating cash flow: 2068500000
Depreciation & amortization: 456870000
Net tangible assets: 782046000
Owner earnings: 2028462000
Return on net tangible assets (%): 259.37886006705486
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 166.63
P/E ratio: 42.42608425723725
Shares outstanding: 400147000
Book value: 4316372000
P/B ratio: 15.44734666289189
Market cap (USD): 66676494610
Debt to equity: 0.618130226032418
Current ratio: 1.7419600233850454
Quick ratio: 0.9487798595475354
Effective tax rate (%): 20.370686575785292
Interest coverage ratio: 20.534375620408973
COGS to revenue (%): 51.165947576306856
SG&A to revenue (%): 27.27819132058544
Free cash flow (dilution-adjusted): 1542045000
Buyback yield (%): 1.0498947254119901
Retained earnings: 10617955000
Inventory turnover: 3.385538613226508
Receivables turnover: 7.713192282158077
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.18186673075126
FCF margin (%): 16.068634617518782
Revenue growth (%): 8.85737818220963
Rule of 40 score: 24.92601279972841
Financial ratios for CTAS — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 198.29
Shares outstanding: 400147000
Market cap (USD): 79345148630
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTAS — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 222.84
Shares outstanding: 400147000
Market cap (USD): 89168757480
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTAS — quarterly report dated 2025-02-28
Total revenue: 2609159000
Gross profit: 1319341000
Operating income: 609853000
Net income: 463497000
Capital expenditures: 18064000
Operating cash flow: 620496000
Depreciation & amortization: 125523000
Net tangible assets: 923359000
Owner earnings: 570956000
Return on net tangible assets (%): 61.83467102178027
Capex to operating income (%): 2.962025274943306
Buffett classification: The Great
Stock price: 205.18
P/E ratio: 44.28408461111938
Shares outstanding: 400147000
Book value: 4592248000
P/B ratio: 17.878425002308237
Market cap (USD): 82102161460
Debt to equity: 0.5861708688206735
Current ratio: 1.721368717242289
Quick ratio: 0.937880509760729
Effective tax rate (%): 20.964023477332642
Interest coverage ratio: 24.6265950573413
COGS to revenue (%): 49.43424298787464
SG&A to revenue (%): 27.192210210263152
Free cash flow (dilution-adjusted): 488771000
Buyback yield (%): 0.032412057766548354
Retained earnings: 11507826000
Inventory turnover: 0.8480818481587781
Receivables turnover: 1.8657012900370187
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.951157693817071
FCF margin (%): 18.73289439240767
Rule of 40 score: 18.73289439240767
Financial ratios for CTAS — annual report dated 2025-05-31
Total revenue: 10340181000
Gross profit: 5174164000
Operating income: 2359726000
Net income: 1812281000
Capital expenditures: 23972000
Operating cash flow: 2165905000
Depreciation & amortization: 494183000
Net tangible assets: 974426000
Owner earnings: 2282492000
Return on net tangible assets (%): 234.2396446728638
Capex to operating income (%): 1.0158806573305545
Buffett classification: The Great
Stock price: 224.37
P/E ratio: 49.540320949124336
Shares outstanding: 400147000
Book value: 4684481000
P/B ratio: 19.165619924597838
Market cap (USD): 89780982390
Debt to equity: 0.566654235549253
Current ratio: 2.089489097611313
Quick ratio: 1.1258119479331736
Effective tax rate (%): 19.95939408233011
Interest coverage ratio: 23.338667563397554
COGS to revenue (%): 49.960605138343325
SG&A to revenue (%): 27.218459715550438
Free cash flow (dilution-adjusted): 1628692000
Buyback yield (%): 1.0412004581764522
Retained earnings: 11798451000
Inventory turnover: 3.2597918056196202
Receivables turnover: 7.295272760111784
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.84490019789166
FCF margin (%): 15.751097587169896
Revenue growth (%): 7.748211218226427
Rule of 40 score: 23.499308805396325
Financial ratios for CTAS — quarterly report dated 2025-05-31
Total revenue: 2667652000
Gross profit: 1325989000
Operating income: 597452000
Net income: 448256000
Capital expenditures: 0
Operating cash flow: 635749000
Depreciation & amortization: 121889000
Net tangible assets: 974426000
Owner earnings: 570145000
Return on net tangible assets (%): 58.51085664791375
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 224.37
P/E ratio: 98.47072879387291
Shares outstanding: 400147000
Book value: 4684481000
P/B ratio: 19.165619924597838
Market cap (USD): 89780982390
Debt to equity: 0.566654235549253
Current ratio: 2.089489097611313
Quick ratio: 1.1258119479331736
Effective tax rate (%): 22.09865922855678
Interest coverage ratio: 24.83175394846218
COGS to revenue (%): 50.29377894867846
SG&A to revenue (%): 27.31004643784122
Free cash flow (dilution-adjusted): 490382000
Buyback yield (%): 0.28588571116881495
Retained earnings: 11798451000
Inventory turnover: 0.846598463246063
Receivables turnover: 1.8820994496186982
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.303154397176098
FCF margin (%): 18.382532654184278
Revenue growth (%): 2.2418334796767847
Rule of 40 score: 20.624366133861063
Financial ratios for CTAS — quarterly report dated 2025-08-31
Total revenue: 2718122000
Gross profit: 1366561000
Operating income: 617859000
Net income: 491140000
Capital expenditures: 101957000
Operating cash flow: 414481000
Depreciation & amortization: 125937000
Net tangible assets: 1046946000
Owner earnings: 515120000
Return on net tangible assets (%): 49.2021556030588
Capex to operating income (%): 16.501661382289488
Buffett classification: The Great
Stock price: 208.48
P/E ratio: 59.464725078819264
Shares outstanding: 400147000
Book value: 4755700000
P/B ratio: 17.541612498685787
Market cap (USD): 83422646560
Debt to equity: 0.5625388481190992
Current ratio: 2.2389464517956066
Quick ratio: 1.1631807265991476
Effective tax rate (%): 17.58109906411571
Interest coverage ratio: 25.572575638425562
COGS to revenue (%): 49.72407419534517
SG&A to revenue (%): 27.544826906224223
Free cash flow (dilution-adjusted): 282176000
Buyback yield (%): 0.31897453625930616
Retained earnings: 12107250000
Inventory turnover: 0.8332373648323737
Receivables turnover: 1.9127600987159468
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.417389777104591
FCF margin (%): 10.381285313904232
Revenue growth (%): 1.8919259333676206
Rule of 40 score: 12.273211247271853
Financial ratios for CTAS — quarterly report dated 2025-11-30
Total revenue: 2799992000
Gross profit: 1412485000
Operating income: 655714000
Net income: 495343000
Capital expenditures: 106252000
Operating cash flow: 531223000
Depreciation & amortization: 127501000
Net tangible assets: 674114000
Owner earnings: 516592000
Return on net tangible assets (%): 76.6327357093904
Capex to operating income (%): 16.204015775170273
Buffett classification: The Great
Stock price: 185.09
P/E ratio: 39.01685998474373
Shares outstanding: 400147000
Book value: 4455347000
P/B ratio: 16.623443298580337
Market cap (USD): 74063208230
Debt to equity: 0.7265573253890213
Current ratio: 1.705257022570009
Quick ratio: 0.9051019154762678
Effective tax rate (%): 21.18697733029543
Interest coverage ratio: 23.35496509474284
COGS to revenue (%): 49.553963011322885
SG&A to revenue (%): 27.02761293603696
Free cash flow (dilution-adjusted): 392618000
Buyback yield (%): 0.8581453803975998
Retained earnings: 12421850000
Inventory turnover: 0.8352890537050527
Receivables turnover: 1.8863701284352246
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.138543677366568
FCF margin (%): 14.022111491747118
Revenue growth (%): 3.0120060836121407
Rule of 40 score: 17.03411757535926
Financial ratios for DRUG — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.71
Shares outstanding: 9812061
Market cap (USD): 350388698.31
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRUG — annual report dated 2022-09-30
Total revenue: 0
Operating income: -14975092
Net income: -14964941
Capital expenditures: 0
Operating cash flow: -13587116
Depreciation & amortization: 6037
Net tangible assets: 10542512
Owner earnings: -14958904
Return on net tangible assets (%): -141.89126841876018
Buffett classification: The Gruesome
Stock price: 6.15
Shares outstanding: 9812061
Book value: 10542512
P/B ratio: 5.7238896337039975
Market cap (USD): 60344175.150000006
Debt to equity: 0.013271125515436927
Current ratio: 8.114234469663272
Quick ratio: 8.114234469663272
Free cash flow (dilution-adjusted): -14462172
Buyback yield (%): 0
Retained earnings: -24174798
Receivables turnover: 0
Capitalized R&D asset: 12180938
ROCI (R&D-adjusted, %): -30.06947341893732
Rule of 40 score: 0
Financial ratios for DRUG — annual report dated 2023-09-30
Total revenue: 0
Operating income: -7386414
Net income: -7372225
Capital expenditures: 0
Operating cash flow: -7024265
Depreciation & amortization: 72450
Net tangible assets: 6598216
Owner earnings: -7299775
Return on net tangible assets (%): -110.63255583024261
Buffett classification: The Gruesome
Stock price: 1.6
Shares outstanding: 9812061
Book value: 6598216
P/B ratio: 2.3793245931930693
Market cap (USD): 15699297.600000001
Debt to equity: 0.0111468008928474
Current ratio: 24.25676859315806
Quick ratio: 24.25676859315806
Free cash flow (dilution-adjusted): -8176396
Buyback yield (%): 0
Retained earnings: -31547023
Receivables turnover: 0
Capitalized R&D asset: 13161172.46
ROCI (R&D-adjusted, %): -41.06114257073858
Rule of 40 score: 0
Financial ratios for DRUG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.17
Shares outstanding: 9812061
Market cap (USD): 11480111.37
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRUG — annual report dated 2024-09-30
Total revenue: 0
Operating income: -2822767
Net income: -2801946
Capital expenditures: 0
Operating cash flow: -1850186
Depreciation & amortization: 73357
Net tangible assets: 5536343
Owner earnings: -2728589
Return on net tangible assets (%): -49.28504249104508
Buffett classification: The Gruesome
Stock price: 1.17
Shares outstanding: 9812061
Book value: 5536343
P/B ratio: 2.073591063631715
Market cap (USD): 11480111.37
Debt to equity: 0.02148710800613329
Current ratio: 11.324260473667586
Quick ratio: 11.324260473667586
Free cash flow (dilution-adjusted): -2689957
Buyback yield (%): 0
Retained earnings: -34348969
Receivables turnover: 0
Capitalized R&D asset: 8549682.02
ROCI (R&D-adjusted, %): -54.9573382565589
Rule of 40 score: 0